For the quarter ending 2026-03-31, DMAC has $53,080K in assets. $4,868K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Deposits | - | - | 200 | 200 |
| Cash and cash equivalents | 4,868 | 15,647 | 3,326 | 4,109 |
| Marketable securities | 46,463 | 44,243 | 51,992 | 25,929 |
| Prepaid expenses and other assets | 731 | 481 | 445 | 680 |
| Amounts receivable | 301 | 258 | 260 | 161 |
| Total current assets | 52,363 | 60,629 | 56,223 | 31,079 |
| Deferred offering costs | 400 | 400 | 456 | - |
| Operating lease right-of-use asset | 175 | 197 | 218 | 239 |
| Property, plant and equipment, gross | 301 | 295 | 289 | - |
| Less accumulated depreciation | 159 | 150 | 139 | - |
| Property and equipment, net | 142 | 145 | 150 | 152 |
| Deposits | - | 0 | 0 | 0 |
| Total non-current assets | 717 | 742 | 824 | 391 |
| Total assets | 53,080 | 61,371 | 57,047 | 31,470 |
| Accounts payable | 3,293 | 1,475 | 1,920 | 1,261 |
| Accrued liabilities | 2,340 | 3,545 | 3,239 | 2,747 |
| Operating lease obligation | 104 | 101 | 99 | 96 |
| Finance lease obligation | 11 | 11 | 10 | 12 |
| Total current liabilities | 5,748 | 5,132 | 5,268 | 4,116 |
| Operating lease obligation | 96 | 124 | 150 | 176 |
| Finance lease obligation, non-current | 1 | 4 | 7 | 8 |
| Common shares, no par value unlimited authorized 43,072,488 and 42,818,660 shares issued and outstanding, as of june 30, 2025 and december 31, 2024, respectively | - | - | - | 0 |
| Total non-current liabilities | 97 | 128 | 157 | 184 |
| Paid-in capital | 230,071 | 228,829 | 215,600 | 182,592 |
| Accumulated other comprehensive income | -26 | 50 | 50 | -14 |
| Accumulated deficit | -182,810 | -172,768 | -164,028 | -155,408 |
| Total shareholders equity | 47,235 | 56,111 | 51,622 | 27,170 |
| Total liabilities and shareholders equity | 53,080 | 61,371 | 57,047 | 31,470 |
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)